Update shared on 15 Dec 2025
Fair value Decreased 4.12%Analysts have trimmed their price target on Peoplein from approximately $1.21 to $1.16 per share. This reflects more cautious assumptions on revenue growth and profit margins, partially offset by a slightly higher future earnings multiple.
Valuation Changes
- Fair Value: Reduced slightly from A$1.21 to A$1.16 per share, reflecting a modest downgrade in intrinsic value estimates.
- Discount Rate: Risen slightly from 8.60 percent to about 8.76 percent, implying a marginally higher required return and risk assessment.
- Revenue Growth: Fallen significantly from around 1.23 percent to about 0.52 percent, indicating more conservative expectations for top line expansion.
- Net Profit Margin: Trimmed from roughly 1.22 percent to about 1.08 percent, pointing to slightly lower anticipated profitability.
- Future P/E: Increased moderately from about 13.4x to 14.8x, suggesting a somewhat higher valuation multiple on forecast earnings despite softer fundamentals.
Have other thoughts on Peoplein?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.